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Abstract Extensive internalization into endothelial cells has 
been found for a water soluble amphipathic 26-mer ß-sheet 
peptide (FLUOS-DPKGDPKGVTVTVTVTVTGKGDPKPD-
NH2; VT5). With the D-Val
13,D-Thr14 di-D-amino acid analog 
of VT5 (DD-VT5), exhibiting an identical primary structure but 
no propensity to adopt a ß-sheet conformation, only about 5% of 
the cellular uptake of VT5 was found. The mechanism of entry of 
VT5 into the cells remained unclear, but proved to be energy, 
temperature and pH dependent and, therefore, clearly distinct 
from that reported for helical amphipathic peptides. No 
detectable cytotoxicity, high solubility in water and the found 
extensive entry into endothelial cells make VT5 appear a good 
lead for developing new types of vectors for delivering 
oligonucleotides and peptides into intact cells. 
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1. Introduction 
Peptides exhibiting the propensity to form amphipathic 
helices at water-lipid interfaces have repeatedly been shown 
to be capable of crossing plasma membranes of mammalian 
cells [1-4]. Such peptides could be translocated into the cell 
interior at low micromolar concentrations without any detect-
able impairment of the cell viability and could be exploited 
successfully as vectors for oligonucleotides and oligopeptides 
[2,5]. The mechanism for the translocation across the plasma 
membrane has remained unclear, so far [1,6]. 
Beta-sheet forming peptides appeared not to be good can-
didates for such an application due to their aggregation ten-
dency in water and, therefore, very limited solubility. 
Recently, however, the synthesis of a water soluble amphi-
pathic 26-mer ß-sheet peptide has been reported by our group 
[7]. The solubility in water was achieved by attaching two 
unstructured charged hydrophilic octapeptides to a central 
(Val-Thr)5 ß-sheet sequence [7]. In the present study we report 
on the internalization into endothelial cells of a fluorescein 
labelled derivative of this water soluble ß-sheet peptide 
(FLUOS-DPKGDPKGVTVTVTVTVTGKGDPKPD-NH2; 
VT5) being comparably extensive to that observed with helical 
peptides. This finding introduces new aspects into the discus-
sion about the still unclear mechanisms for the passage of 
structure forming peptides through biological membranes 
and probably opens the way for exploiting ß-sheet peptides 
as vectors for delivering oligonucleotides and oligopeptides 
into the cell interior. 
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2. Materials and methods 
2.1. Peptide synthesis 
VT5 and its D-Val13,D-Thr14 double-D-amino acid analog were syn-
thesized automatically by solid phase methods using standard Fmoc 
chemistry as described previously [7]. To introduce the fluorescence 
label, the peptides were N-terminally conjugated with 5(6)- carboxy-
fluorescein-W-hydroxysuccinimide ester (FLUOS; Boehringer, Mann-
heim) (2 equiv. in DMF), and the final cleavage was performed with 
95% trifluoroacetic acid (TFA)/5% water for 3 h. 
2.2. Cell culture 
Calf aortic endothelial cells (AEC), at the 12th to 20th subculture of 
a cell line established and characterized by Halle et al. [8], were seeded 
at an initial density 5X 104 cells/cm2 into 24-well culture plates. The 
cells were cultured at 37°C in a humidified 5% CO2 containing air 
environment in minimal essential medium (MEM; Sigma GmbH, Dei-
senhofen) supplemented with 290 mg/1 glutamine and 10% fetal bo-
vine serum (Sigma). After 4 days without replacing the medium, the 
cells were used for the uptake experiments. 
2.3. Uptake experiments 
After removal of the medium the cell layers were rinsed twice at 
37°C with Dulbecco's phosphate buffered saline (DPBS; Biochrom 
KG, Berlin) and subsequently exposed, unless indicated otherwise, 
at 37°C for 30 min to the peptide solutions in DPBS. Thereafter the 
incubation solutions were removed, the cells were washed twice with 
ice-cold PBS, incubated with 250 μΐ of ice-cold PBS and treated with 
diazotized 2-nitroaniline as described previously [9] in order to modify 
surface bound peptide. Briefly, to 400 μΐ ethanol/water 1/1 v/v con-
taining 2-nitroaniline (0.06 M) and HC1 (0.125 M) 50 μΐ 0.6 M 
NaNÜ2 was added. After standing for 5 min at ambient temperature, 
5 μΐ of this reagent was added to the ice-cold PBS covering the cell 
layer and allowed to react for 10 min at 0°C. After aspiration of the 
diazo reagent the cells were again washed twice with ice-cold PBS and 
finally lysed with 0.2 ml 0.1% Triton X-100 containing 10 mmol/1 
TFA for 2 h at 0°C. The resulting lysate was used for HPLC analysis 
and for determining the protein amount according to Bradford [10]. 
The protein content of 106 cells assayed by this method amounted to 
110 μg. The average volume of the used cells was determined to be 1.4 
pi by means of a Coulter ZM counter (Coulter Electronics ltd., Luton, 
England). 
2.4. HPLC analysis 
HPLC was performed using a Bischoff HPLC- radient system 
(Leonberg, Germany) equipped with a Polyencap A 300, 5 μpiι column 
(250x4 mm I.D.), precolumns containing the same sorbent, a Rheo-
dyne-RH 8125 injection valve with a 50 μΐ sample loop and a fluo-
rescence HPLC Monitor RF-551 (Shimadzu). 
70 μΐ of the cell lysates was mixed with 30 μΐ of 0.1 M TFA in 
acetonitrile/water 1/1 and injected without further pretreatment into 
the sample loop. Alternatively, to enhance the assayed peptide quan-
tity, up to 200 μΐ of the lysates was concentrated on a Polyencap A 
300 precolumn, which subsequently was connected with the HPLC 
system. The elution was carried out with 0.01 M TFA (A) and ace-
tonitrile/water 9/1 (B) with gradients of 30^10% B (0-15 min) and 40-
80% B (15-20 min) at a flow rate of 1.0 ml/min. Quantitation was 
performed by fluorescence measurement at 520 nm after excitation at 
445 nm by means of calibration lines obtained with the parent pep-
tides using analogous conditions. 
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2.5. Confocal laser scanning microscopy (CLSM) 
104 cells were plated on 22x22 mm coverslips glued (with Silicones 
RTV 615A/615B, Paul Hellermann GmbH, Pinneberg) above the hole 
(15 mm diameter) of punched plastic Costar culture dishes (35 mm 
diameter; Tecnomara Deutschland GmbH, Frankfurt/Main) and cul-
tured, exposed to peptides and washed as described above. After 
subsequently covering the cells with about 200 μΐ PBS, microscopy 
was performed within 10 min at room temperature using a LSM 410 
invert confocal laser scanning microscope (Carl Zeiss Jena GmbH, 
Jena, Germany). Excitation was performed at 488 nm by means of 
an argon-krypton laser and a dichroitic mirror (FT 510) for wave-
length selection. Emission was measured upon 515 nm by use of a cut-
off filter (LP 515) in front of the detector. For optical sectioning in the 
z-direction 16 frames with a thickness of 1 μηι were made. 
3. Results 
3.1. Extensive internalization of VT5 into endothelial cells 
Exposure of bovine AEC to the fluorescently labelled β-
sheet model peptide VT5 resulted in high quantities of cell 
associated peptide. Treatment of the peptide exposed cells 
with diazotized o-nitroaniline, a reagent proven to modify 
the surface bound but not the internalized amino group con-
taining compounds [9], reduced the HPLC peak of VT5 by 
about 30%, suggesting the remainder to be internalized. 
CSLM of the peptide treated cells supported this notion by 
revealing extensive cell internal fluorescence (Fig. 1). Consid-
ering the ratio of cell volume to protein content of about 15 
μΐ/mg protein determined for AEC (see Section 2) the quanti-
ties of internalized peptide correspond to an up to sixfold 
enrichment within the cell interior (Figs. 2-A). 
3.2. Role of the ß-sheet forming propensity of VT5 for its entry 
into the cells 
To elucidate the role of the ß-sheet forming propensity of 
VT5 for its internalization into the cells, we exposed AEC in 
parallel to VT5 and DD-VT5, the D-Val13,D-Thr14 di-D-amino 
acid analog of VT5, exhibiting an identical primary structure 




Fig. 2. Quantity of cell associated peptide after exposing AEC to 
different concentrations of VT5 for 30 min at 37°C. Each point rep-
resents the mean of three samples ± S.D. 
the di-D-amino acid analog only about 5% of the peptide 
quantity obtained with VT5 using identical conditions was 
found to be cell associated (not shown). This finding clearly 
demonstrates dependence of the predominant part of the VT5 
internalization on the ß-sheet forming propensity of this pep-
tide. 
Surprisingly, with respect to number and fluorescence inten-
sity of the fluorescent vesicles, the CLSM image of the cells 
treated with DD-VT5 appeared to be comparable to that ex-
posed to VT5 (displayed in Fig. 1). The only difference that 
could be additionally found in the VT5 treated cells was a 
faint fluorescence of the entire cytosol. This finding suggests 
comparable uptake into endocytic vesicles for DD-VT5 and a 
portion of VT5 corresponding to the amount of taken up DD-
VT5 (about 5% of cell associated VT5, see above). It appears 
likely that this portion of internalized peptide is accounted for 
by non-specific adsorptive endocytosis mediated by electro-
static interactions between the negatively charged phospholip-
id head groups of the plasma membrane and the protonated 
amino groups being identical in both peptides. Likewise such 
interpretation suggests the predominant, ß-sheet dependent, 
quantity of the internalized VT5 to be taken up by a mecha-
nism other than non-specific adsorptive endocytosis. 
Attempts to investigate effects of an increased ß-sheet 
forming propensity by examining the cellular uptake of VT5 
analogs possessing six and seven central Val-Thr ß-sheet 
forming repeats failed, since extensive self aggregation around 
pH 7 prevented precise uptake measurements with these pep-
tides. 
Fig. 1. CLSM image of a 1 μpiι thick central horizontal optical sec-
tion through AEC exposed before to 8 μΜ VT5 in DPBSG for 30 
min at 37°C. Insert: the same section viewed in transmission mode. 
3.3. Investigations into the mechanism of uptake 
The concentration dependence of the VT5 uptake into the 
cells exhibited a complex course suggesting an overlay of sat-
urable and unsaturable processes (Fig. 2). 
To obtain further information about the mode of uptake, 
particularly to address the question of whether the internal-
ization of this ß-sheet peptide proceeds in a non-endocytic 
way as reported for a-helical amphipathic peptides [1,4,6], 
we investigated effects of several agents known to affect endo-
cytosis. 
The uptake exhibited strong energy, temperature and pH 
dependence (Fig. 3) and could be prevented quantitatively by 
the presence of hyperosmolar sucrose (450 mM) in the incu-
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bation solution. Such behavior is commonly regarded as char-
acteristic of endocytic uptake [11,12]. 
On the other hand, the time course of uptake differed 
strongly from that determined for lucifer yellow, commonly 
considered to be a membrane impermeable marker for fluid 
phase endocytosis [13] (Fig. 4). For uptake by adsorptive en-
docytosis, however, irrespective of quantitative differences a 
time course parallel to that of fluid phase endocytosis is to be 
expected. A peculiar behavior of our endothelial cell line ap-
pears unlikely to account for this discrepancy since the found 
uptake of lucifer yellow agreed well with that reported by 
Guillot et al. [14]. 
No significant efflux of peptide out of preloaded cells (30 
min, 37°C, 10 μΜ peptide) could be observed during 30 min 
at 37°C (not shown). This finding also contradicts an endo-
cytic mechanism, since the high cellular uptake observed with-
in 30 min, if accounted for by a corresponding extensive endo-
somal turnover, should result in a measurable efflux within the 
same period. 
A lack of influence upon the cellular VT5 uptake of brefel-
din A (5 μΜ), a reagent which perturbs the endosomal trans-
port [15], points in the same direction (Fig. 3). 
Vincristine (20 μΜ), an inhibitor of the transport of lip-
ophilic peptides by the multidrug resistance transporter gp 
170 [16], did not affect the uptake so that the involvement 
of mdrp-like peptide transporters in the translocation of 
VT5 appears unlikely (Fig. 3). 
Addition of 10% fetal bovine serum remained without in-
fluence on the uptake suggesting a negligible influence of non-
specific protein binding for entry and escape into or from the 
plasma membrane, respectively. 
3.4. Toxicity and metabolic breakdown of VT5 
Perforation of the plasma membrane could be ruled out to 
account for the observed peptide internalization within the 
investigated concentration range by trypan blue exclusion 
and a lack of liberation of lactic dehydrogenase. The MTT 
viability test [17] resulted in identical values for controls and 
control DOG/Na- 0 °C pH 6,0 monensin vincristine brefeldin 
azide A 
Fig. 3. Quantity of cell associated peptide after exposing AEC for 
30 min to 8 μΜ VT5 in DPBSG at 37°C (control), at 37°C in 
DPBS containing 25 mM 2-deoxyglucose/10 mM Na-azide (DOG/ 
Na-azide), in DPBSG adjusted with HC1 to pH 6.0 (pH 6.0), in 
DPBSG containing 20 μΜ monensin (monensin) or 20 μΜ vincris-
tine (vincristine) or 5 μΜ brefeldin A (brefeldin A), and in DPBSG 
at 0°C (0°C). Before exposure to the peptide the cells were incu-
bated for 60 min at 37°C in DPBSG or 25 mM 2-deoxyglucose/10 
mM Na-azide in DPBS or in DPBSG at 0°C. Each bar represents 
the mean of three samples ± S.D. 
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Fig. 4. Quantity of cell associated peptide after exposing AEC to 8 
μΜ VT5 or 1 mM lucifer yellow in DPBSG at 37°C for different 
periods of time. Each point represents the mean of three sam-
ples! S.D. 
cells treated with VT5 under the conditions used for the up-
take studies. 
No metabolic breakdown exceeding 10% of the peptide 
amount could be detected in either the incubation solution 
or the cell interior. 
4. Discussion 
The results of the present work reveal an extensive internal-
ization into endothelial cells of a model peptide forming an 
amphipathic ß-sheet at solid lipid/water interphases and in the 
presence of SDS without participation of helical structures [7]. 
A corresponding structure forming behavior of the peptide 
was observed in the presence of DOPC vesicles (Krause et 
al., unpublished). Because of analogy to the conditions used 
for the uptake experiments, a strong propensity to adopt a ß-
sheet can be expected for this peptide also at the interface 
between incubation solution and plasma membrane of the 
cells. 
Comparable cellular uptake had been found before only for 
a-helical amphipathic peptides, some of which could be ex-
ploited successfully as vectors for translocating membrane im-
permeable peptides and oligonucleotides across the plasma 
membrane of mammalian cells [2,5]. VT5 also exhibited con-
siderable helix forming propensity in 50% TFE/water [7]. This 
ability, however, appears not relevant in the context of the 
present cellular uptake experiments considering the peculiar 
structure inducing properties of TFE [18] and the poor anal-
ogy between the conditions in TFE/water and at lipid/water 
interphases. 
The helical peptides were taken up to the greatest part in an 
uncleared, but energy and temperature independent and, 
therefore, non-endocytic way [1,4]. In contrast, strong energy 
and temperature dependence was found in the present study 
for the internalization of the ß-sheet peptide VT5, implying a 
mode of uptake distinct from that of the a-helical amphi-
pathic peptides. As a further difference from the helical pep-
tides, no propensity to destabilize plasma membranes could be 
detected for VT5 within the low micromolar concentration 
range. 
The mechanism for the internalization of VT5 remains un-
clear. Strong arguments exist for as well as against an endo-
cytic mechanism. 
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Besides the observed energy and temperature dependence, 
the reduced VT5 internalization at pH 6 or in the presence of 
the acidifying reagent monensin [19] and the slow down of the 
uptake by hyperosmolar sucrose resemble effects commonly 
regarded to be characteristic of clathrin dependent endocyto-
sis [11,12]. In the same way, the time course of VT5 uptake, 
approaching no equilibrium within 90 min, appears reconcil-
able with an endocytic mechanism, considering half-life times 
for plasma membrane recycling of various cell types in the 
range of 30 min to several hours [11,20]. 
On the other hand, several of our findings make it unlikely 
that endocytosis is the mechanism of the predominant part of 
peptide internalization and induce us to look for alternative 
interpretations. In particular, the observed up to sixfold en-
richment of VT5 within the cell interior in relation to a total 
volume of the endocytic compartment of maximally about 
10% of the cell volume [11,14], its retention within the cell 
interior and the discrepancy between the uptake kinetics of 
VT5 and that of the pinocytic marker lucifer yellow appear 
difficult to reconcile with an endocytic mechanism. Further-
more, in the case of non-specific adsorptive endocytosis, elec-
trostatic interactions between the charged groups of the plas-
ma membrane and that of the peptides, being identical for 
VT5 and its double-D analog, should predominate and, in 
strong contrast to our findings, result in comparable uptake 
of both peptides. 
As an additional argument against an endocytic mechanism 
it should be noted that the aspects appearing characteristic of 
clathrin dependent endocytosis might also be explainable by 
translocation events mediated by carrier proteins or proceed-
ing across protein channels, often found to exhibit pH and 
energy dependence [21-23]. In the same way, the effect of 
hyperosmolar sucrose might be interpreted, apart from slow 
down of endocytosis, simply by effects of membrane shrinking 
accompanying the hyperosmolar stress [24]. 
In conclusion, a comparably extensive cellular uptake com-
bined with a reduced toxicity and a distinct mode of entry 
into the cell interior make VT5-like ß-sheet peptides promis-
ing alternatives to a-helical amphipathic peptides to serve as 
vectors for translocating oligonucleotides and membrane im-
permeable peptides into mammalian cells. More detailed stud-
ies into the mechanism and to elucidate the possibility of 
exploiting ß-sheet peptides as transport vectors for oligonu-
cleotides and peptides are under way. 
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